BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25808322)

  • 1. Metastasis suppressor NME1 regulates melanoma cell morphology, self-adhesion and motility via induction of fibronectin expression.
    Novak M; Leonard MK; Yang XH; Kowluru A; Belkin AM; Kaetzel DM
    Exp Dermatol; 2015 Jun; 24(6):455-61. PubMed ID: 25808322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.
    Leonard MK; Novak M; Snyder D; Snow G; Pamidimukkala N; McCorkle JR; Yang XH; Kaetzel DM
    Exp Cell Res; 2019 Jan; 374(1):85-93. PubMed ID: 30458180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma.
    Kaetzel DM; Leonard MK; Cook GS; Novak M; Jarrett SG; Yang X; Belkin AM
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Feb; 388(2):199-206. PubMed ID: 25017017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.
    McCorkle JR; Leonard MK; Kraner SD; Blalock EM; Ma D; Zimmer SG; Kaetzel DM
    Cancer Genomics Proteomics; 2014; 11(4):175-94. PubMed ID: 25048347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis Suppressor NME1 Directly Activates Transcription of the
    Pamidimukkala NV; Leonard MK; Snyder D; McCorkle JR; Kaetzel DM
    Anticancer Res; 2018 Nov; 38(11):6059-6068. PubMed ID: 30396920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells.
    Olbryt M; Habryka A; Tyszkiewicz T; Rusin A; Cichoń T; Jarząb M; Krawczyk Z
    Melanoma Res; 2011 Oct; 21(5):417-25. PubMed ID: 21912348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 is highly metastatic in vivo.
    Snyder D; Wang Y; Kaetzel DM
    Sci Rep; 2020 Feb; 10(1):1971. PubMed ID: 32029850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NME1 Drives Expansion of Melanoma Cells with Enhanced Tumor Growth and Metastatic Properties.
    Wang Y; Leonard MK; Snyder DE; Fisher ML; Eckert RL; Kaetzel DM
    Mol Cancer Res; 2019 Aug; 17(8):1665-1674. PubMed ID: 31123173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
    Khan I; Gril B; Steeg PS
    Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NME1 suppression promotes growth, adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu.
    Li MQ; Shao J; Meng YH; Mei J; Wang Y; Li H; Zhang L; Chang KK; Wang XQ; Zhu XY; Li DJ
    Hum Reprod; 2013 Oct; 28(10):2822-31. PubMed ID: 23856325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.
    Delyon J; Khayati F; Djaafri I; Podgorniak MP; Sadoux A; Setterblad N; Boutalbi Z; Maouche K; Maskos U; Menashi S; Lebbé C; Mourah S
    Exp Dermatol; 2015 Jun; 24(6):443-8. PubMed ID: 25807898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NME1 at the human maternal-fetal interface downregulates titin expression and invasiveness of trophoblast cells via MAPK pathway in early pregnancy.
    Xie KM; Hou XF; Li MQ; Li DJ
    Reproduction; 2010 Apr; 139(4):799-808. PubMed ID: 20145075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma.
    Leonard MK; McCorkle JR; Snyder DE; Novak M; Zhang Q; Shetty AC; Mahurkar AA; Kaetzel DM
    Lab Invest; 2018 Mar; 98(3):327-338. PubMed ID: 29058705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma.
    Novak M; Jarrett SG; McCorkle JR; Mellon I; Kaetzel DM
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):433-8. PubMed ID: 21448569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells.
    McCarthy JB; Hagen ST; Furcht LT
    J Cell Biol; 1986 Jan; 102(1):179-88. PubMed ID: 3941152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nme1 and Nme2 genes exert metastasis-suppressor activities in a genetically engineered mouse model of UV-induced melanoma.
    Pamidimukkala N; Puts GS; Kathryn Leonard M; Snyder D; Dabernat S; De Fabo EC; Noonan FP; Slominski A; Merlino G; Kaetzel DM
    Br J Cancer; 2021 Jan; 124(1):161-165. PubMed ID: 33024267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility.
    Przybyło M; Pocheć E; Link-Lenczowski P; Lityńska A
    Mol Vis; 2008 Mar; 14():625-36. PubMed ID: 18385798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.